| - Industry | - Sector | Mr. Michael Rodyniuk CEO | TSX-V Exchange | - ISIN |
| Canada Country | - Employees | - Last Dividend | 23 Apr 2024 Last Split | - IPO Date |
FluroTech Ltd. is a pioneering company based in Calgary, Canada, that specializes in the development and commercialization of advanced fluorescence spectroscopy technologies. Their expertise lies primarily in leveraging this technology for highly efficient and reliable COVID-19 testing solutions. The essence of their innovation revolves around enhancing the diagnostic processes, thereby contributing significantly to the control and management of this global pandemic. By integrating cutting-edge scientific research with practical applications, FluroTech aims to set new benchmarks in the healthcare and diagnostics industries.
COVID-19 Testing Kits: FluroTech offers advanced testing kits designed for the rapid and accurate detection of the COVID-19 virus. Utilizing fluorescence spectroscopy technology, these kits aim to provide results with higher accuracy rates compared to traditional testing methods. Ideal for both medical facilities and research institutions, FluroTech's COVID-19 testing kits are pivotal in the efforts to manage and mitigate the spread of the virus.